| GO | Name | 
		| GO:0000082 | G1/S transition of mitotic cell cycle | 
		| GO:0000122 | negative regulation of transcription by RNA polymerase II | 
		| GO:0000165 | MAPK cascade | 
		| GO:0000785 | chromatin | 
		| GO:0000978 | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 
		| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific | 
		| GO:0001046 | core promoter sequence-specific DNA binding | 
		| GO:0001227 | DNA-binding transcription repressor activity, RNA polymerase II-specific | 
		| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | 
		| GO:0001658 | branching involved in ureteric bud morphogenesis | 
		| GO:0002053 | positive regulation of mesenchymal cell proliferation | 
		| GO:0003677 | DNA binding | 
		| GO:0003700 | DNA-binding transcription factor activity | 
		| GO:0005634 | nucleus | 
		| GO:0005654 | nucleoplasm | 
		| GO:0005730 | nucleolus | 
		| GO:0006112 | energy reserve metabolic process | 
		| GO:0006338 | chromatin remodeling | 
		| GO:0006357 | regulation of transcription by RNA polymerase II | 
		| GO:0006879 | cellular iron ion homeostasis | 
		| GO:0006974 | cellular response to DNA damage stimulus | 
		| GO:0007219 | Notch signaling pathway | 
		| GO:0008134 | transcription factor binding | 
		| GO:0008284 | positive regulation of cell population proliferation | 
		| GO:0010332 | response to gamma radiation | 
		| GO:0010468 | regulation of gene expression | 
		| GO:0010628 | positive regulation of gene expression | 
		| GO:0015671 | oxygen transport | 
		| GO:0016579 | protein deubiquitination | 
		| GO:0019221 | cytokine-mediated signaling pathway | 
		| GO:0032204 | regulation of telomere maintenance | 
		| GO:0032873 | negative regulation of stress-activated MAPK cascade | 
		| GO:0032986 | protein-DNA complex disassembly | 
		| GO:0032991 | protein-containing complex | 
		| GO:0034644 | cellular response to UV | 
		| GO:0035690 | cellular response to drug | 
		| GO:0042493 | response to drug | 
		| GO:0043066 | negative regulation of apoptotic process | 
		| GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 
		| GO:0044346 | fibroblast apoptotic process | 
		| GO:0044877 | protein-containing complex binding | 
		| GO:0045656 | negative regulation of monocyte differentiation | 
		| GO:0045893 | positive regulation of transcription, DNA-templated | 
		| GO:0045944 | positive regulation of transcription by RNA polymerase II | 
		| GO:0046983 | protein dimerization activity | 
		| GO:0048146 | positive regulation of fibroblast proliferation | 
		| GO:0048147 | negative regulation of fibroblast proliferation | 
		| GO:0050679 | positive regulation of epithelial cell proliferation | 
		| GO:0051276 | chromosome organization | 
		| GO:0051782 | negative regulation of cell division | 
		| GO:0051973 | positive regulation of telomerase activity | 
		| GO:0070371 | ERK1 and ERK2 cascade | 
		| GO:0070848 | response to growth factor | 
		| GO:0070888 | E-box binding | 
		| GO:0071456 | cellular response to hypoxia | 
		| GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 
		| GO:1904672 | regulation of somatic stem cell population maintenance | 
		| GO:1904837 | beta-catenin-TCF complex assembly | 
		| GO:1905643 | positive regulation of DNA methylation | 
		| GO:2000573 | positive regulation of DNA biosynthetic process | 
		| GO:2001022 | positive regulation of response to DNA damage stimulus |